BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26180083)

  • 1. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients.
    Harshyne LA; Nasca BJ; Kenyon LC; Andrews DW; Hooper DC
    Neuro Oncol; 2016 Feb; 18(2):206-15. PubMed ID: 26180083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.
    Domenis R; Cesselli D; Toffoletto B; Bourkoula E; Caponnetto F; Manini I; Beltrami AP; Ius T; Skrap M; Di Loreto C; Gri G
    PLoS One; 2017; 12(1):e0169932. PubMed ID: 28107450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Magnetic Resonance Imaging with Systemic Monocyte Evaluation for the Implementation of GBM Management.
    Giordano C; Sabatino G; Romano S; Della Pepa GM; Tufano M; D'Alessandris QG; Cottonaro S; Gessi M; Balducci M; Romano MF; Olivi A; Gaudino S; Colosimo C
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Heterotypic Tridimensional Model to Study the Interaction of Macrophages and Glioblastoma In Vitro.
    Gattas MJ; Estecho IG; Lago Huvelle MA; Errasti AE; Carrera Silva EA; Simian M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
    de Vrij J; Maas SL; Kwappenberg KM; Schnoor R; Kleijn A; Dekker L; Luider TM; de Witte LD; Litjens M; van Strien ME; Hol EM; Kroonen J; Robe PA; Lamfers ML; Schilham MW; Broekman ML
    Int J Cancer; 2015 Oct; 137(7):1630-42. PubMed ID: 25802036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic Cancer-Secreted Exosomal miR-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-like Factor 2 and 4.
    Li J; Yuan H; Xu H; Zhao H; Xiong N
    Mol Cancer Res; 2020 Aug; 18(8):1218-1231. PubMed ID: 32366676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
    van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
    Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.
    Lamano JB; Lamano JB; Li YD; DiDomenico JD; Choy W; Veliceasa D; Oyon DE; Fakurnejad S; Ampie L; Kesavabhotla K; Kaur R; Kaur G; Biyashev D; Unruh DJ; Horbinski CM; James CD; Parsa AT; Bloch O
    Clin Cancer Res; 2019 Jun; 25(12):3643-3657. PubMed ID: 30824583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis.
    Nijaguna MB; Patil V; Urbach S; Shwetha SD; Sravani K; Hegde AS; Chandramouli BA; Arivazhagan A; Marin P; Santosh V; Somasundaram K
    J Biol Chem; 2015 Sep; 290(38):23401-15. PubMed ID: 26245897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.
    Bloch O; Crane CA; Kaur R; Safaee M; Rutkowski MJ; Parsa AT
    Clin Cancer Res; 2013 Jun; 19(12):3165-75. PubMed ID: 23613317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FKBP51s Splice Isoform Predicts Unfavorable Prognosis in Patients with Glioblastoma.
    Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S
    Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness.
    Pace KR; Dutt R; Galileo DS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.
    Rodrigues JC; Gonzalez GC; Zhang L; Ibrahim G; Kelly JJ; Gustafson MP; Lin Y; Dietz AB; Forsyth PA; Yong VW; Parney IF
    Neuro Oncol; 2010 Apr; 12(4):351-65. PubMed ID: 20308313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts.
    Prosniak M; Harshyne LA; Gorky J; Curtis MT; Kenyon LC; Schwaber JS; Lebrun A; Kean RB; Andrews DW; Hooper DC
    J Immunol; 2021 Apr; 206(7):1483-1492. PubMed ID: 33685995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.